112 related articles for article (PubMed ID: 7438675)
1. Effects of thyroid dysfunction on propranolol kinetics.
Riddell JG; Neill JD; Kelly JG; McDevitt DG
Clin Pharmacol Ther; 1980 Nov; 28(5):565-74. PubMed ID: 7438675
[TBL] [Abstract][Full Text] [Related]
2. No enhanced elimination of propranolol in patients with hyperthyroidism.
Ishizaki T; Masuno M; Tawara K
Res Commun Chem Pathol Pharmacol; 1980 Sep; 29(3):473-85. PubMed ID: 7423023
[TBL] [Abstract][Full Text] [Related]
3. Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.
Hallengren B; Nilsson OR; Karlberg BE; Melander A; Tegler L; Wåhlin-Boll E
Eur J Clin Pharmacol; 1982; 21(5):379-84. PubMed ID: 7075643
[TBL] [Abstract][Full Text] [Related]
4. Oxazepam pharmacokinetics in thyroid disease.
Scott AK; Khir AS; Bewsher PD; Hawksworth GM
Br J Clin Pharmacol; 1984 Jan; 17(1):49-53. PubMed ID: 6419761
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of propranolol and sotalol in hyperthyroidism.
Aro A; Anttila M; Korhonen T; Sundquist H
Eur J Clin Pharmacol; 1982; 21(5):373-7. PubMed ID: 7075642
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of theophylline in hyperthyroid and hypothyroid patients with chronic obstructive pulmonary disease.
Pokrajac M; Simić D; Varagić VM
Eur J Clin Pharmacol; 1987; 33(5):483-6. PubMed ID: 3428340
[TBL] [Abstract][Full Text] [Related]
7. Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects.
Smallridge RC; Wartofsky L; Desjardins RE; Burman KD
J Clin Endocrinol Metab; 1978 Aug; 47(2):345-9. PubMed ID: 263302
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man.
Nicoloff JT; Low JC; Dussault JH; Fisher DA
J Clin Invest; 1972 Mar; 51(3):473-83. PubMed ID: 4110897
[TBL] [Abstract][Full Text] [Related]
9. Studies of the effect of thyroid dysfunction on the elimination of beta-adrenoreceptor blocking drugs.
Bell JM; Russell CJ; Nelson JK; Kelly JG; McDevitt DG
Br J Clin Pharmacol; 1977 Feb; 4(1):79-82. PubMed ID: 14661
[No Abstract] [Full Text] [Related]
10. Amiodarone pharmacokinetics. III. Influence of thyroid dysfunction on amiodarone absorption and disposition.
Weir SJ; Ueda CT
J Pharmacol Exp Ther; 1988 Sep; 246(3):1026-32. PubMed ID: 3418508
[TBL] [Abstract][Full Text] [Related]
11. Absence of changes in drug disposition and catecholamine sensitivity in the hyperthyroid dog.
Ishizaki T; Tawara K
Br J Pharmacol; 1980; 71(1):143-55. PubMed ID: 7470733
[TBL] [Abstract][Full Text] [Related]
12. Influence of mild thyroid dysfunction on antipyrine clearance and metabolite formation in man.
Teunissen MW; van der Veen EA; Doodeman PJ; Breimer DD
Eur J Clin Pharmacol; 1984; 27(1):99-103. PubMed ID: 6489432
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of propranolol in healthy cats during euthyroid and hyperthyroid states.
Jacobs G; Whittem T; Sams R; Calvert C; Ferguson D
Am J Vet Res; 1997 Apr; 58(4):398-403. PubMed ID: 9099387
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of thyrotrophin-releasing hormone in patients in different thyroid states.
Iversen E
J Endocrinol; 1991 Jan; 128(1):153-9. PubMed ID: 1900321
[TBL] [Abstract][Full Text] [Related]
15. Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing.
Wells PG; Feely J; Wilkinson GR; Wood AJ
Clin Pharmacol Ther; 1983 May; 33(5):603-8. PubMed ID: 6839632
[TBL] [Abstract][Full Text] [Related]
16. Unaltered metabolism of phenytoin in thyroid disorders.
Mølholm Hansen J; Skovsted L; Kampmann JP; Lumholtz BI; Siersbaek-Nielsen K
Acta Pharmacol Toxicol (Copenh); 1978 May; 42(5):343-6. PubMed ID: 581029
[TBL] [Abstract][Full Text] [Related]
17. Plasma protein binding of propranolol and isoprenaline in hyperthyroidism and hypothyroidism.
Kelly JG; McDevitt DG
Br J Clin Pharmacol; 1978 Aug; 6(2):123-7. PubMed ID: 678388
[TBL] [Abstract][Full Text] [Related]
18. Effects of thyroid status on atrial natriuretic peptide release from isolated rat atria.
Wong NL; Huang D; Guo NS; Wong EF; Hu DC
Am J Physiol; 1989 Jan; 256(1 Pt 1):E64-7. PubMed ID: 2521429
[TBL] [Abstract][Full Text] [Related]
19. The calcium pump of cardiac sarcoplasmic reticulum. Functional alterations at different levels of thyroid state in rabbits.
Suko J
J Physiol; 1973 Feb; 228(3):563-82. PubMed ID: 4267211
[TBL] [Abstract][Full Text] [Related]
20. Substrate cycling between gluconeogenesis and glycolysis in euthyroid, hypothyroid, and hyperthyroid man.
Shulman GI; Ladenson PW; Wolfe MH; Ridgway EC; Wolfe RR
J Clin Invest; 1985 Aug; 76(2):757-64. PubMed ID: 4031071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
